 |
|
Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea
Jeong Han Kim, Yong Joon Cho, Won Hyeok Choe, So Young Kwon, Byung-Chul Yoo
Korean J Intern Med. 2024;39(2):248-260. Published online 2024 Feb 1 DOI: https://doi.org/10.3904/kjim.2023.005
|
|
Citations to this article as recorded by
 Preliminary experience of combined dual plasma molecular adsorption system and plasma exchange in pediatric acute liver failure: a retrospective case series
Jia-Hao Geng, Shi-Lin Liu, Bao-Fan Dou, Jun-Lin Zhao, He-Kai Ma, Zhi-Yuan Wang, Shu-Jun Li
BMC Pediatrics.2025;[Epub] CrossRef Comparison of Mortality Prediction Between the Model for End-Stage Liver Disease-3.0 (MELD-3.0) and the Model for End-Stage Liver Disease-Lactate (MELD-La) in Korean Patients with Liver Cirrhosis
Seung-Kang Yoo, Jeong-Han Kim, Won-Hyeok Choe, So-Young Kwon
Medicina.2025; 61(3): 494. CrossRef Prevalence and prognostic significance of cachexia diagnosed by novel definition for Asian population among Chinese cirrhotic patients
Shuangzhe Yao, Ziyi Yang, Jia Li, Binbin Peng, Han Wang, Jing Liang, Chao Sun
Archives of Gerontology and Geriatrics.2025; 133: 105833. CrossRef
|